Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235M Buy
2,195,000
+295,000
+16% +$32.5M 5.02% 4
2026
Q1
$200M Sell
1,900,000
-700,000
-27% -$82.2M 9.59% 3
2025
Q4
$324M Buy
2,600,000
+435,000
+20% +$51.8M 4.46% 6
2025
Q3
$260M Sell
2,165,000
-425,000
-16% -$44.9M 2.89% 13
2025
Q2
$238M Sell
2,590,000
-125,000
-5% -$11.4M 3.12% 12
2025
Q1
$239M Hold
2,715,000
3.65% 6
2024
Q4
$251M Buy
2,715,000
+665,000
+32% +$64M 3.38% 9
2024
Q3
$190M Buy
2,050,000
+1,400,000
+215% +$118M 2.56% 17
2024
Q2
$48.7M Buy
+650,000
New +$51.9M 0.56% 31

Other funds holding CRH

Daniel Loeb's CRH Position: Q2 2026 in Review

Daniel Loeb increased its CRH (CRH) stake by 16% in Q2 2026, buying an estimated $32.5M and bringing the position to 2,195,000 shares worth $235M. The position accounts for 5.02% of the portfolio, ranked #4.

Daniel Loeb first reported a position in CRH in Q2 2024 and has held it in 9 quarters since. The position peaked at $324M in Q4 2025. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Daniel Loeb held 2,195,000 shares of CRH worth $235M as of Q2 2026.
  • Daniel Loeb bought 295,000 CRH shares in Q2 2026, an estimated $32.5M.
  • CRH made up 5.02% of Daniel Loeb's portfolio in Q2 2026, its #4 holding.
  • Daniel Loeb first reported a position in CRH in Q2 2024 and has held it in 9 quarters since.
  • Daniel Loeb's CRH position peaked at $324M in Q4 2025.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Third Point's 13F filing for Q2 2026, filed 14 Aug 2026.